spacer
spacer
Go to PDB code: 
protein metals links
Hydrolase PDB id
1bt7
Jmol
Contents
Protein chain
165 a.a.
Metals
_ZN
PDB id:
1bt7
Name: Hydrolase
Title: The solution nmr structure of the n-terminal protease domain of the hepatitis c virus (hcv) ns3-protein, from bk strain, 20 structures
Structure: Ns3 serine protease. Chain: a. Engineered: yes. Mutation: yes. Other_details: compound engineered adding a solubilising tail at thE C-terminus
Source: Hepatitis c virus. Organism_taxid: 11103. Strain: bk. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
NMR struc: 20 models
Authors: G.Barbato,D.O.Cicero,M.C.Nardi,C.Steinkuhler,R.Cortese,R.De Francesco,R.Bazzo
Key ref:
G.Barbato et al. (1999). The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism. J Mol Biol, 289, 371-384. PubMed id: 10366511 DOI: 10.1006/jmbi.1999.2745
Date:
01-Sep-98     Release date:   22-Jun-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P26663  (POLG_HCVBK) -  Genome polyprotein
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
3010 a.a.
165 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 10 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.7.48  - RNA-directed Rna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1)
Nucleoside triphosphate
+ RNA(n)
= diphosphate
+ RNA(n+1)
   Enzyme class 2: E.C.3.4.21.98  - Hepacivirin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
   Enzyme class 3: E.C.3.6.1.15  - Nucleoside-triphosphatase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: NTP + H2O = NDP + phosphate
NTP
+ H(2)O
= NDP
+ phosphate
   Enzyme class 4: E.C.3.6.4.13  - Rna helicase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + H2O = ADP + phosphate
ATP
+ H(2)O
= ADP
+ phosphate
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     transformation of host cell by virus   2 terms 
  Biochemical function     catalytic activity     2 terms  

 

 
    reference    
 
 
DOI no: 10.1006/jmbi.1999.2745 J Mol Biol 289:371-384 (1999)
PubMed id: 10366511  
 
 
The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanism.
G.Barbato, D.O.Cicero, M.C.Nardi, C.Steinkühler, R.Cortese, R.De Francesco, R.Bazzo.
 
  ABSTRACT  
 
The solution structure of the hepatitis C virus (BK strain) NS3 protein N-terminal domain (186 residues) has been solved by NMR spectroscopy. The protein is a serine protease with a chymotrypsin-type fold, and is involved in the maturation of the viral polyprotein. Despite the knowledge that its activity is enhanced by the action of a viral protein cofactor, NS4A, the mechanism of activation is not yet clear. The analysis of the folding in solution and the differences from the crystallographic structures allow the formulation of a model in which, in addition to the NS4A cofactor, the substrate plays an important role in the activation of the catalytic mechanism. A unique structural feature is the presence of a zinc-binding site exposed on the surface, subject to a slow conformational exchange process.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. A stereoview of the 20 minimum-energy structures is shown. For the overlay, the SCR residues identifying the β-strands plus the helicoidal segments were used. Due to its peculiar mobility, see the NS4a interaction section, strand D1 was omitted in the calculation of the r.m.s.d. The first 21 residues were not included in the structure calculation, because for them no structural information was available.
Figure 7.
Figure 7. Zoomed view of the substrate interaction region. The S′ and S regions range approximately from strand A1 (identified by the position of T38) to loop E2-F2 (G162), encompassing the rather flat surface defined by the E2 strand (F154 bottom of recognition pocket, A157 H-bond candidate with substrate P3 partner) on one side and the α2 helix (oxyanion hole G137-S139; L135 delimiting the top side of the recognition pocket) on the other side.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (1999, 289, 371-384) copyright 1999.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21194118 M.Geitmann, G.Dahl, and U.H.Danielson (2011).
Mechanistic and kinetic characterization of hepatitis C virus NS3 protein interactions with NS4A and protease inhibitors.
  J Mol Recognit, 24, 60-70.  
20405151 A.Peres-da-Silva, A.J.de Almeida, and E.Lampe (2010).
Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients.
  Arch Virol, 155, 807-811.  
18795894 Y.Zhou, W.P.Tzeng, Y.Ye, Y.Huang, S.Li, Y.Chen, T.K.Frey, and J.J.Yang (2009).
A cysteine-rich metal-binding domain from rubella virus non-structural protein is essential for viral protease activity and virus replication.
  Biochem J, 417, 477-483.  
18215275 C.Welsch, F.S.Domingues, S.Susser, I.Antes, C.Hartmann, G.Mayr, A.Schlicker, C.Sarrazin, M.Albrecht, S.Zeuzem, and T.Lengauer (2008).
Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus.
  Genome Biol, 9, R16.  
18799730 V.Brass, J.M.Berke, R.Montserret, H.E.Blum, F.Penin, and D.Moradpour (2008).
Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex.
  Proc Natl Acad Sci U S A, 105, 14545-14550.  
18411324 W.Yang, Y.Zhao, J.Fabrycki, X.Hou, X.Nie, A.Sanchez, A.Phadke, M.Deshpande, A.Agarwal, and M.Huang (2008).
Selection of replicon variants resistant to ACH-806, a novel hepatitis C virus inhibitor with no cross-resistance to NS3 protease and NS5B polymerase inhibitors.
  Antimicrob Agents Chemother, 52, 2043-2052.  
17094110 C.Oliva, A.Rodríguez, M.González, and W.Yang (2007).
A quantum mechanics/molecular mechanics study of the reaction mechanism of the hepatitis C virus NS3 protease with the NS5A/5B substrate.
  Proteins, 66, 444-455.  
17869377 R.De Francesco, and A.Carfí (2007).
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
  Adv Drug Deliv Rev, 59, 1242-1262.  
17509079 S.Melino, and M.Paci (2007).
Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
  FEBS J, 274, 2986-3002.  
17671755 T.Suzuki, H.Aizaki, K.Murakami, I.Shoji, and T.Wakita (2007).
Molecular biology of hepatitis C virus.
  J Gastroenterol, 42, 411-423.  
16972281 H.Zhou, N.J.Singh, and K.S.Kim (2006).
Homology modeling and molecular dynamics study of West Nile virus NS3 protease: a molecular basis for the catalytic activity increased by the NS2B cofactor.
  Proteins, 65, 692-701.  
16415022 N.J.Baxter, A.Roetzer, H.D.Liebig, S.E.Sedelnikova, A.M.Hounslow, T.Skern, and J.P.Waltho (2006).
Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart disease.
  J Virol, 80, 1451-1462.
PDB code: 1z8r
16911516 S.Melino, S.Fucito, A.Campagna, F.Wrubl, A.Gamarnik, D.O.Cicero, and M.Paci (2006).
The active essential CFNS3d protein complex.
  FEBS J, 273, 3650-3662.  
15681139 U.C.Chaturvedi, and R.Shrivastava (2005).
Interaction of viral proteins with metal ions: role in maintaining the structure and functions of viruses.
  FEMS Immunol Med Microbiol, 43, 105-114.  
15155230 L.Lu, T.J.Pilot-Matias, K.D.Stewart, J.T.Randolph, R.Pithawalla, W.He, P.P.Huang, L.L.Klein, H.Mo, and A.Molla (2004).
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro.
  Antimicrob Agents Chemother, 48, 2260-2266.  
14701815 M.J.Richer, L.Juliano, C.Hashimoto, and F.Jean (2004).
Serpin mechanism of hepatitis C virus nonstructural 3 (NS3) protease inhibition: induced fit as a mechanism for narrow specificity.
  J Biol Chem, 279, 10222-10227.  
15048818 M.Shokhen, and A.Albeck (2004).
Identification of protons position in acid-base enzyme catalyzed reactions: the hepatitis C viral NS3 protease.
  Proteins, 55, 245-250.  
15564480 P.Niyomrattanakit, P.Winoyanuwattikun, S.Chanprapaph, C.Angsuthanasombat, S.Panyim, and G.Katzenmeier (2004).
Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.
  J Virol, 78, 13708-13716.  
12646587 A.Pause, G.Kukolj, M.Bailey, M.Brault, F.Dô, T.Halmos, L.Lagacé, R.Maurice, M.Marquis, G.McKercher, C.Pellerin, L.Pilote, D.Thibeault, and D.Lamarre (2003).
An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA.
  J Biol Chem, 278, 20374-20380.  
12610142 C.Trozzi, L.Bartholomew, A.Ceccacci, G.Biasiol, L.Pacini, S.Altamura, F.Narjes, E.Muraglia, G.Paonessa, U.Koch, R.De Francesco, C.Steinkuhler, and G.Migliaccio (2003).
In vitro selection and characterization of hepatitis C virus serine protease variants resistant to an active-site peptide inhibitor.
  J Virol, 77, 3669-3679.  
  12556211 F.Narjes, U.Koch, and C.Steinkühler (2003).
Recent developments in the discovery of hepatitis C virus serine protease inhibitors--towards a new class of antiviral agents?
  Expert Opin Investig Drugs, 12, 153-163.  
12882616 M.P.Walker, N.Yao, and Z.Hong (2003).
Promising candidates for the treatment of chronic hepatitis C.
  Expert Opin Investig Drugs, 12, 1269-1280.  
12192066 A.Casbarra, F.D.Piaz, P.Ingallinella, S.Orrù, P.Pucci, A.Pessi, and E.Bianchi (2002).
The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure.
  Protein Sci, 11, 2102-2112.  
  11841941 S.J.Archer, D.M.Camac, Z.J.Wu, N.A.Farrow, P.J.Domaille, Z.R.Wasserman, M.Bukhtiyarova, C.Rizzo, S.Jagannathan, L.J.Mersinger, and C.A.Kettner (2002).
Hepatitis C virus NS3 protease requires its NS4A cofactor peptide for optimal binding of a boronic acid inhibitor as shown by NMR.
  Chem Biol, 9, 79-92.  
15989494 B.W.Dymock (2001).
Emerging therapies for hepatitis C virus infection.
  Expert Opin Emerg Drugs, 6, 13-42.  
11170379 U.Koch, G.Biasiol, M.Brunetti, D.Fattori, M.Pallaoro, and C.Steinkühler (2001).
Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization.
  Biochemistry, 40, 631-640.  
10809747 D.Fattori, A.Urbani, M.Brunetti, R.Ingenito, A.Pessi, K.Prendergast, F.Narjes, V.G.Matassa, R.De Francesco, and C.Steinkühler (2000).
Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer.
  J Biol Chem, 275, 15106-15113.  
10677236 F.Narjes, M.Brunetti, S.Colarusso, B.Gerlach, U.Koch, G.Biasiol, D.Fattori, R.De Francesco, V.G.Matassa, and C.Steinkühler (2000).
Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease.
  Biochemistry, 39, 1849-1861.  
10702283 S.Di Marco, M.Rizzi, C.Volpari, M.A.Walsh, F.Narjes, S.Colarusso, R.De Francesco, V.G.Matassa, and M.Sollazzo (2000).
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes.
  J Biol Chem, 275, 7152-7157.
PDB codes: 1dxp 1dy8 1dy9
10864639 T.Ueno, S.Misawa, Y.Ohba, M.Matsumoto, M.Mizunuma, N.Kasai, K.Tsumoto, I.Kumagai, and H.Hayashi (2000).
Isolation and characterization of monoclonal antibodies that inhibit hepatitis C virus NS3 protease.
  J Virol, 74, 6300-6308.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.